Neuropace, Inc.
NPCE • NASDAQ
Neuropace, Inc. is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Joel D. Becker, with a market cap of $448.8M.
CEOJoel D. Becker
Next Earnings
Upcoming earnings announcement for Neuropace, Inc.
Date
Tuesday, May 12, 2026 (in a month)
Timing
After Market Close (4:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.21
Revenue Estimate
$21.6M
Earnings History
Past 12 earnings reports for Neuropace, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 3, 2026 | Q4 2025 | -$0.08Est: -$0.15 | +46.7% | $26.6MEst: $25.3M | +5.3% |  10-K |
| Nov 4, 2025 | Q3 2025 | -$0.11Est: -$0.20 | +45.0% | $27.4MEst: $24.6M | +11.2% | 10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.26Est: -$0.23 | -13.0% | $23.5MEst: $23.2M | +1.4% | 10-Q |
| May 13, 2025 | Q1 2025 | -$0.21Est: -$0.24 | +12.5% | $22.5MEst: $21.9M | +3.1% | 10-Q |
| Mar 4, 2025 | Q4 2024 | -$0.18Est: -$0.22 | +18.2% | $21.5MEst: $21.1M | +1.5% | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.19Est: -$0.27 | +29.6% | $21.1MEst: $19.1M | +10.4% | 10-Q |
| Aug 13, 2024 | Q2 2024 | -$0.26Est: -$0.30 | +13.3% | $19.3MEst: $18.3M | +5.2% | 10-Q |
| May 8, 2024 | Q1 2024 | -$0.32Est: -$0.32 | 0.0% | $18.1MEst: $17.3M | +4.8% | 10-Q |
| Mar 5, 2024 | Q4 2023 | -$0.23Est: -$0.31 | +25.8% | $18.0MEst: $17.5M | +3.2% | 10-K |
| Nov 6, 2023 | Q3 2023 | -$0.28Est: -$0.41 | +31.7% | $16.4MEst: $14.2M | +15.5% | — |
| Aug 8, 2023 | Q2 2023 | -$0.36Est: -$0.46 | +21.7% | $16.5MEst: $12.6M | +30.8% | 10-Q |
| May 4, 2023 | Q1 2023 | -$0.41Est: -$0.46 | +10.9% | $14.5MEst: $12.2M | +18.9% | — |